Our publications

2024

Joint host-pathogen genomic analysis identifies hepatitis B virus mutations associated with human NTCP and HLA class I variation

Z. M. Xu; G. E. Gnouamozi; S. Rueger; P. R. Shea; M. Buti et al. 

American Journal Of Human Genetics. 2024-06-06. Vol. 111, num. 6. DOI : 10.1016/j.ajhg.2024.04.013.

Antibody-peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins

A. S. Petruzzella; M. Bruand; A. Santamaria-Martinez; N. Katanayeva; L. Reymond et al. 

Nature Chemical Biology. 2024-05-29. DOI : 10.1038/s41589-024-01627-z.

Opportunities and challenges in design and optimization of protein function

D. Listov; C. A. Goverde; B. E. Correia; S. J. Fleishman 

Nature Reviews Molecular Cell Biology. 2024-04-02. DOI : 10.1038/s41580-024-00718-y.

A Synthetic Multivalent Lipopeptide Derived from Pam3CSK4 with Irreversible Influenza Inhibition and Immuno-Stimulating Effects

Y. Zhu; L. Wei; A. C-A. Zwygart; P. Gainza; Q. O. Khac et al. 

Small. 2024-03-04. DOI : 10.1002/smll.202307709.

Past, present, and future of CRISPR genome editing technologies

M. Pacesa; O. Pelea; M. Jinek 

Cell. 2024-02-29. Vol. 187, num. 5, p. 1076-1100. DOI : 10.1016/j.cell.2024.01.042.

An atlas of protein homo-oligomerization across domains of life

H. Schweke; M. Pacesa; T. Levin; C. A. Goverde; P. Kumar et al. 

Cell. 2024-02-15. Vol. 187, num. 4. DOI : 10.1016/j.cell.2024.01.022.

Engineering novel protein interactions with therapeutic potential using deep learning-guided surface design

A. Marchand / B. E. Ferreira De Sousa Correia (Dir.)  

Lausanne, EPFL, 2024. 

Predicting protein interactions using geometric deep learning on protein surfaces

F. Sverrisson / B. E. Ferreira De Sousa Correia; M. Bronstein (Dir.)  

Lausanne, EPFL, 2024. 

2023

A new age in protein design empowered by deep learning

H. Khakzad; I. Igashov; A. Schneuing; C. Goverde; M. Bronstein et al. 

Cell Systems. 2023-11-15. Vol. 14, num. 11, p. 925-939. DOI : 10.1016/j.cels.2023.10.006.

Protein-based bandpass filters for controlling cellular signaling with chemical inputs

S. Shui; L. Scheller; B. E. Correia 

Nature Chemical Biology. 2023-11-13. DOI : 10.1038/s41589-023-01463-7.

Deformation response of highly stretchable and ductile graphene kirigami under uniaxial and biaxial tension

P. Shi; Y. Chen; Y. Wei; J. Feng; T. Guo et al. 

Physical Review B. 2023-10-09. Vol. 108, num. 13, p. 134105. DOI : 10.1103/PhysRevB.108.134105.

Rational design of small-molecule responsive protein switches

S. Shui; S. Buckley; L. Scheller; B. E. Correia 

Protein Science. 2023-10-01. Vol. 32, num. 10, p. e4774. DOI : 10.1002/pro.4774.

Rules and mechanisms governing G protein coupling selectivity of GPCRs

I. Masuho; R. Kise; P. Gainza; E. Von Moo; X. Li et al. 

Cell Reports. 2023-09-23. Vol. 42, num. 10, p. 113173. DOI : 10.1016/j.celrep.2023.113173.

Discriminating physiological from non‐physiological interfaces in structures of protein complexes: A community‐wide study

H. Schweke; Q. Xu; G. Tauriello; L. Pantolini; T. Schwede et al. 

PROTEOMICS. 2023-06-27. Vol. [early access], p. e2200323. DOI : 10.1002/pmic.202200323.

Rational Design of Chemically Controlled Antibodies and Protein Therapeutics

A. Marchand; L. Bonati; S. Shui; L. Scheller; P. Gainza Cirauqui et al. 

ACS Chemical Biology. 2023-05-30. Vol. 18, num. 6, p. 1259-1265. DOI : 10.1021/acschembio.3c00012.

De novo protein design by inversion of the AlphaFold structure prediction network

C. Goverde; B. Wolf; H. Khakzad; S. Rosset; B. Correia 

Protein Science. 2023-05-10. Vol. 36, num. 6, p. e4653. DOI : 10.1002/pro.4653.

New protein–protein interactions designed by a computer

A. Marchand; P. Gainza Cirauqui 

Nature. 2023-04-26. DOI : 10.1038/d41586-023-01324-2.

De novo design of protein interactions with learned surface fingerprints

P. Gainza Cirauqui; S. Wehrle; A. K. Van Hall-Beauvais; A. Marchand; A. Scheck et al. 

Nature. 2023-04-26. Vol. 617, num. 7959, p. 176-184. DOI : 10.1038/s41586-023-05993-x.

A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response

L. Rubio-Perez; R. Lazaro-Gorines; S. L. Harwood; M. Compte; R. Navarro et al. 

Oncoimmunology. 2023-12-31. Vol. 12, num. 1, p. 2205336. DOI : 10.1080/2162402X.2023.2205336.

Multienzyme deep learning models improve peptide de novo sequencing by mass spectrometry proteomics

C. Gueto-Tettay; D. Tang; L. Happonen; M. Heusel; H. Khakzad et al. 

Plos Computational Biology. 2023-01-01. Vol. 19, num. 1, p. e1010457. DOI : 10.1371/journal.pcbi.1010457.

Track: Machine Learning in Protein Science De Novo Design of Viral Epitope Mimetics with Non-Regular Structural Features

K. Castro; J. Wang; L. Milles; J. Watson; R. Ragotte et al. 

2023-01-01. 36th Annual Symposium of the Protein-Society, San Francisco, CA, Jul 07-10, 2022.

De novo designed proteins: a study in engineering novel folds and functions

A. K. Van Hall-Beauvais / B. E. Ferreira De Sousa Correia (Dir.)  

Lausanne, EPFL, 2023. 

2022

Computational design of vaccine immunogens

K. M. Castro; A. Scheck; S. Xiao; B. E. Correia 

Current Opinion In Biotechnology. 2022-12-01. Vol. 78, p. 102821. DOI : 10.1016/j.copbio.2022.102821.

A generic framework for hierarchical de novo protein design

Z. Harteveld; J. Bonet; S. Rosset; C. Yang; F. Sesterhenn et al. 

Proceedings Of The National Academy Of Sciences Of The United States Of America. 2022-10-25. Vol. 119, num. 43, p. e2206111119. DOI : 10.1073/pnas.2206111119.

Assessing and enhancing foldability in designed proteins

D. Listov; R. Lipsh-Sokolik; S. Rosset; C. Yang; B. E. Correia et al. 

Protein Science. 2022-09-01. Vol. 31, num. 9, p. e4400. DOI : 10.1002/pro.4400.

Antibodies to combat viral infections: development strategies and progress

G. Pantaleo; B. Correia; C. Fenwick; V. S. Joo; L. Perez 

Nature Reviews Drug Discovery. 2022-06-20. Vol. 21, p. 676–696. DOI : 10.1038/s41573-022-00495-3.

Computational design of novel protein–protein interactions – An overview on methodological approaches and applications

A. Marchand; A. K. Van Hall-Beauvais; B. Correia 

Current Opinion in Structural Biology. 2022-04-09. Vol. 74, p. 102370. DOI : 10.1016/j.sbi.2022.102370.

Invasive Streptococcal Infection Can Lead to the Generation of Cross-Strain Opsonic Antibodies

T. de Neergaard; A. Blaeckberg; H. Ivarsson; S. Thomasson; V. K. Ahnlide et al. 

Microbiology Spectrum. 2022-10-31. DOI : 10.1128/spectrum.02486-22.

Programmable DARPin-based receptors for the detection of thrombotic markers

T. Strittmatter; Y. Wang; A. Bertschi; L. Scheller; P. C. Freitag et al. 

Nature Chemical Biology. 2022-08-08. DOI : 10.1038/s41589-022-01095-3.

Novel chemically controlled cellular switches

B. E. Correia; S. Shui; P. Gainza Cirauqui 

WO2022156885.

2022.

A method and system for fast end-to-end learning on protein surfaces

M. Bronstein; F. Sverrisson; J. Pierre Feydy; P. Gainza; B. Ferreira De Sousa Correia 

WO2022152478.

2022.

Towards automating de novo protein design for novel functionalities: controlling protein folds and protein-protein interactions

Z. Harteveld / B. E. Ferreira De Sousa Correia (Dir.)  

Lausanne, EPFL, 2022. 

Targeting molecular surfaces to engineer novel protein-based immunogens and inhibitors

S. Wehrle / B. E. Ferreira De Sousa Correia (Dir.)  

Lausanne, EPFL, 2022. 

Rational design of protein switches: applications in synthetic biology and cancer immunotherapy

S. Shui / B. E. Ferreira De Sousa Correia (Dir.)  

Lausanne, EPFL, 2022. 

2021

De Novo Design of Site-specific Protein Binders Using Surface Fingerprints

S. Wehrle; A. Van Hall-Beauvais; P. Gainza; Z. Harteveld; A. Scheck et al. 

2021-10-01.  p. 162-163.

Computational design of bioactive protein switches with multi-logics for cell-based therapeutics

S. Shui; P. Gainza; L. Scheller; C. Yang; B. Correia 

2021-10-01.  p. 37-37.

A Nanoscaffolded Spike-RBD Vaccine Provides Protection against SARS-CoV-2 with Minimal Anti-Scaffold Response

D. Lainšček; T. Fink; V. Forstnerič; I. Hafner-Bratkovič; S. Orehek et al. 

Vaccines. 2021-04-27. Vol. 9, num. 5, p. 431. DOI : 10.3390/vaccines9050431.

Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning

D. M. Mason; S. Friedensohn; C. R. Weber; C. Jordi; B. Wagner et al. 

Nature Biomedical Engineering. 2021-04-15. Vol. 5, p. 600–612. DOI : 10.1038/s41551-021-00699-9.

Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design

C. T. Schoeder; S. Schmitz; J. Adolf-Bryfogle; A. M. Sevy; J. A. Finn et al. 

Biochemistry. 2021-03-23. Vol. 60, num. 11, p. 825-846. DOI : 10.1021/acs.biochem.0c00912.

Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein

M. D. Hoffmann; J. Mathony; J. U. Zu Belzen; Z. Harteveld; S. Aschenbrenner et al. 

Nucleic Acids Research. 2021-03-18. Vol. 49, num. 5, p. e29. DOI : 10.1093/nar/gkaa1198.

Bottom-up de novo design of functional proteins with complex structural features

C. Yang; F. Sesterhenn; J. Bonet; E. A. van Aalen; L. Scheller et al. 

Nature Chemical Biology. 2021-01-04. Vol. 17, p. 492–500. DOI : 10.1038/s41589-020-00699-x.

Fast end-to-end learning on protein surfaces

F. Sverrisson; J. Feydy; B. E. Correia; M. M. Bronstein 

2021-01-01. IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), ELECTR NETWORK, Jun 19-25, 2021. p. 15267-15276. DOI : 10.1109/CVPR46437.2021.01502.

On the exploration of novel methodological approaches for immunogen design: case studies in influenza and hepatitis C

A. Scheck / B. E. Ferreira De Sousa Correia (Dir.)  

Lausanne, EPFL, 2021. 

On the use of direct-coupling analysis with a reduced alphabet of amino acids combined with super-secondary structure motifs for protein fold prediction

B. Anton; M. Besalu; O. Fornes; J. Bonet; A. Molina et al. 

Nar Genomics And Bioinformatics. 2021-06-01. Vol. 3, num. 2, p. lqab027. DOI : 10.1093/nargab/lqab027.

Preclinical development of a humanized chimeric antigen receptor against B-cell maturation antigen for multiple myeloma

L. Perez-Amill; G. Sune; A. Antonana-Vildosola; M. Castella; A. Najjar et al. 

Haematologica. 2021-01-01. Vol. 106, num. 1, p. 173-184. DOI : 10.3324/haematol.2019.228577.

SPServer: split-statistical potentials for the analysis of protein structures and protein-protein interactions

J. Aguirre-Plans; A. Meseguer; R. Molina-Fernandez; M. A. Marin-Lopez; G. Jumde et al. 

Bmc Bioinformatics. 2021-01-06. Vol. 22, num. 1, p. 4. DOI : 10.1186/s12859-020-03770-5.

A Rosetta-based protein design protocol converging to natural sequences

G. Sormani; Z. Harteveld; S. Rosset; B. Correia; A. Laio 

Journal Of Chemical Physics. 2021-02-21. Vol. 154, num. 7, p. 074114. DOI : 10.1063/5.0039240.

2020

Oligomerization Profile of Human Transthyretin Variants with Distinct Amyloidogenicity

A. Frangolho; B. Correia; D. C. Vaz; Z. L. Almeida; R. M. M. Brito 

Molecules. 2020-12-03. Vol. 25, num. 23, p. 5698. DOI : 10.3390/molecules25235698.

Picometer Resolution Structure of the Coordination Sphere in the Metal-Binding Site in a Metalloprotein by NMR

A. Bertarello; L. Benda; K. J. Sanders; A. J. Pell; M. J. Knight et al. 

Journal Of The American Chemical Society. 2020-09-30. Vol. 142, num. 39, p. 16757-16765. DOI : 10.1021/jacs.0c07339.

Macromolecular modeling and design in Rosetta: recent methods and frameworks

J. K. Leman; B. D. Weitzner; S. M. Lewis; J. Adolf-Bryfogle; N. Alam et al. 

Nature Methods. 2020-06-01. Vol. 17, p. 665–680. DOI : 10.1038/s41592-020-0848-2.

De novo protein design enables the precise induction of RSV-neutralizing antibodies

F. Sesterhenn; C. Yang; J. Bonet; J. T. Cramer; X. Wen et al. 

Science. 2020-05-15. Vol. 368, num. 6492, p. eaay5051730. DOI : 10.1126/science.aay5051.

Computational design of anti-CRISPR proteins with improved inhibition potency

J. Mathony; Z. Harteveld; C. Schmelas; J. U. zu Belzen; S. Aschenbrenner et al. 

Nature Chemical Biology. 2020-04-13. Vol. 16, p. 725–730. DOI : 10.1038/s41589-020-0518-9.

Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A

K. M. Geiger; D. Guignard; C. Yang; J-P. Bikorimana; B. E. Correia et al. 

Frontiers In Immunology. 2020-03-10. Vol. 11, p. 412. DOI : 10.3389/fimmu.2020.00412.

A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy

G. Giordano-Attianese; P. Gainza; E. Gray-Gaillard; E. Cribioli; S. Shui et al. 

Nature Biotechnology. 2020-02-03. Vol. 38, p. 426–432. DOI : 10.1038/s41587-019-0403-9.

The more the merrier: how homo-oligomerization alters the interactome and function of ribonucleotide reductase

M. J. C. Long; A. Van Hall-Beauvais; Y. Aye 

Current Opinion In Chemical Biology. 2020-02-01. Vol. 54, p. 10-18. DOI : 10.1016/j.cbpa.2019.09.003.

On the prediction of DNA-binding preferences of C2H2-ZF domains using structural models: application on human CTCF

A. Meseguer; F. Arman; O. Fornes; R. Molina-Fernandez; J. Bonet et al. 

Nar Genomics And Bioinformatics. 2020-09-01. Vol. 2, num. 3, p. lqaa046. DOI : 10.1093/nargab/lqaa046.

Immunogen

B. Correia; F. Sesterhenn; C. Yang; J. Bonet 

JP2022542003; US2022249649; EP3758004; CA3145336; WO2020260910.

2020.

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity

V. Agnolon; D. Kiseljak; M. J. Wurm; F. M. Wurm; C. Foissard et al. 

Frontiers In Immunology. 2020-11-04. Vol. 11, p. 586595. DOI : 10.3389/fimmu.2020.586595.

Structural basis for recognition of RALF peptides by LRX proteins during pollen tube growth

S. Moussu; C. Broyart; G. Santos-Fernandez; S. Augustin; S. Wehrle et al. 

Proceedings Of The National Academy Of Sciences Of The United States Of America. 2020-03-31. Vol. 117, num. 13, p. 7494-7503. DOI : 10.1073/pnas.2000100117.

Immunogen

B. Correia; F. Sesterhenn 

WO2020065033; EP3628678.

2020.

Functional de novo Protein Design for Targeted Vaccines and Synthetic Biology Applications

C. Yang / B. E. Ferreira De Sousa Correia (Dir.)  

Lausanne, EPFL, 2020. 

2019

Deciphering interaction fingerprints from protein molecular surfaces using geometric deep learning

P. Gainza; F. Sverrisson; F. Monti; E. Rodolà; D. Boscaini et al. 

Nature Methods. 2019-12-09. Vol. 17, pages184–192(2020), p. 184-192. DOI : 10.1038/s41592-019-0666-6.

Decrypting interaction fingerprints in protein molecular surfaces

P. Gainza; F. Sverrisson; F. Monti; M. Bronstein; B. Correia 

2019-07-01. Joint 12th EBSA European Biophysics Congress / 10th IUPAP International Conference on Biological Physics (ICBP), Madrid, SPAIN, Jul 20-24, 2019. p. S224-S224.

rstoolbox – a Python library for large-scale analysis of computational protein design data and structural bioinformatics

J. Bonet; Z. Harteveld; F. Sesterhenn; A. Scheck; B. E. Correia 

BMC Bioinformatics. 2019-05-15. Vol. 20, num. 240, p. 240. DOI : 10.1186/s12859-019-2796-3.

Engineered Anti-CRISPR Proteins for Precision Control of CRISPR-Cas9

F. Bubeck; M. D. Hoffmann; Z. Harteveld; S. Aschenbrenner; A. Bietz et al. 

2019-04-22. 22nd Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT), Washington, DC, Apr 29-May 02, 2019. p. 297-297.

Alternative interaction sites in the influenza A virus nucleoprotein mediate viral escape from the importin-alpha 7 mediated nuclear import pathway

P. Resa-Infante; J. Bonet; S. Thiele; M. Alawi; S. Stanelle-Bertram et al. 

Febs Journal. 2019-09-01. Vol. 286, num. 17, p. 3374-3388. DOI : 10.1111/febs.14868.

Heterodimeric inactivatable chimeric antigen receptors

G. Coukos; M. Irving; B. Correia; P. Gainza-Cirauqui; G. Giordano Attianese 

US2021113615; EP3774866; WO2019197676.

2019.

Expanding beyond the natural protein repertoire to engineer targeted vaccines and diagnostics

F. Sesterhenn / B. E. Ferreira De Sousa Correia (Dir.)  

Lausanne, EPFL, 2019. 

Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen

J. Munro; F. Sesterhenn; M. Galloux; S. S. Vollers; L. Csepregi et al. 

PLoS Biology. 2019. Vol. 17, num. 2, p. e3000164. DOI : 10.1371/journal.pbio.3000164.

2018

Rosetta FunFolDes – A general framework for the computational design of functional proteins

J. Bonet; S. Wehrle; K. Schriever; C. Yang; A. Billet et al. 

PLoS Computational Biology. 2018-11-01. Vol. 14, num. 11, p. e1006623. DOI : 10.1371/journal.pcbi.1006623.

Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9

F. Bubeck; M. D. Hoffmann; Z. Harteveld; S. Aschenbrenner; A. Bietz et al. 

Nature Methods. 2018-11-01. Vol. 15, num. 11, p. 924-927. DOI : 10.1038/s41592-018-0178-9.

Design and characterization of near-native Ebola GP vaccine candidates: implications for immunogenicity

V. Agnolon; I. Ayadi; J. P. Bikorimana; D. Kiseljak; V. De Vaux et al. 

2018-08-27.  p. 6S-7S.

Expanding the druggable proteome: Ligand and target discovery by fragment-based screening in cells

C. Parker; A. Galmozzi; Y. Wang; B. Correia; E. Saez et al. 

2018-08-19. 256th National Meeting and Exposition of the American-Chemical-Society (ACS) – Nanoscience, Nanotechnology and Beyond, Boston, MA, Aug 19-23, 2018.

Structure-based immunogen design – leading the way to the new age of precision vaccines

F. Sesterhenn; J. Bonet; B. E. Correia 

Current Opinion In Structural Biology. 2018-08-01. Vol. 51, p. 163-169. DOI : 10.1016/j.sbi.2018.06.002.

OFF-switch CAR T cell for safety-enhanced cancer immunotherapy

E. F. Gray-Gaillard; G. G. Attianese; P. Gainza-Cirauqui; S. Vollers; S. Shui et al. 

2018-07-01. Annual Meeting of the American-Association-for-Cancer-Research (AACR), Chicago, IL, Apr 14-18, 2018. DOI : 10.1158/1538-7445.AM2018-2570.

Driving Immune Responses with Synthetic Proteins – Development of De Novo Designed Immunogens to Elicit Respiratory Syncytial Virus Neutralizing Antibodies

F. Sesterhenn; C. Yang; J. Bonet; M. Galloux; X. Wen et al. 

2018-11-01. 32nd Annual Symposium of the Protein-Society, Boston, MA, Jul 09-12, 2018. p. 49-50.

On the mechanisms of protein interactions: predicting their affinity from unbound tertiary structures

M. Marin-Lopez; J. Planas-Iglesias; J. Aguirre-Plans; J. Bonet; J. Garcia-Garcia et al. 

BIOINFORMATICS. 2018. Vol. 34, num. 4, p. 592-598. DOI : 10.1093/bioinformatics/btx616.

Computational protein design – the next generation tool to expand synthetic biology applications

P. Gainza-Cirauqui; B. Correia 

CURRENT OPINION IN BIOTECHNOLOGY. 2018. Vol. 52, p. 145-152. DOI : 10.1016/j.copbio.2018.04.001.

Bispecific light T-cell engagers for gene-based immunotherapy of epidermal growth factor receptor (EGFR)-positive malignancies

K. Molgaard; S. Harwood; M. Compte; N. Merino; J. Bonet et al. 

CANCER IMMUNOLOGY IMMUNOTHERAPY. 2018. Vol. 67, num. 8, p. 1251-1260. DOI : 10.1007/s00262-018-2181-5.

ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy

S. Harwood; A. Alvarez-Cienfuegos; N. Nunez-Prado; M. Compte; S. Hernandez-Perez et al. 

OncoImmunology. 2018. Vol. 7, num. 1, p. e1377874. DOI : 10.1080/2162402X.2017.1377874.

2016

Protein-protein structure prediction by scoring molecular dynamics trajectories of putative poses

E. Sarti; I. Gladich; S. Zamuner; B. E. Correia; A. Laio 

Proteins-Structure Function And Bioinformatics. 2016. Vol. 84, num. 9, p. 1312-1320. DOI : 10.1002/prot.25079.

InteractoMIX: a suite of computational tools to exploit interactomes in biological and clinical research

D. Poglayen; M. Alejandro Marin-Lopez; J. Bonet; O. Fornes; J. Garcia-Garcia et al. 

Biochemical Society Transactions. 2016. Vol. 44, num. 3, p. 917-924. DOI : 10.1042/Bst20150001.

2015

Understanding protein recognition using structural features

M. A. Marin-Lopez; J. Planas-Iglesias; J. Bonet; D. Poglayen; J. Garcia-Garcia et al. 

2015. 29th Annual Symposium of the Protein-Society, Barcelona, SPAIN, JUL 22-25, 2015. p. 245-245.

Proof of principle for epitope-focused vaccine design

B. Correia; J. Bates; R. Loomis; C. Carrico; J. Jardine et al. 

2015. 29th Annual Symposium of the Protein-Society, Barcelona, SPAIN, JUL 22-25, 2015. p. 181-184.